XML 46 R36.htm IDEA: XBRL DOCUMENT v3.7.0.1
Segment Information (Tables)
6 Months Ended
Jun. 30, 2017
Segment Reconciliation [Abstract]  
Reconciliation of Revenue from Segments to Consolidated
The tables below present information about our reportable segments (in thousands):
 
Three Months Ended
 
Six Months Ended
 
June 30,
2017
 
July 1,
2016
 
June 30,
2017
 
July 1,
2016
Segment sales by product line:
 
 
 
 
 
 
 
Medical
 
 
 
 
 
 
 
Cardio & Vascular
$
132,231

 
$
122,253

 
$
257,339

 
$
235,924

Cardiac & Neuromodulation
106,185

 
106,919

 
209,998

 
215,452

Advanced Surgical, Orthopedics & Portable Medical
108,560

 
109,391

 
213,706

 
207,753

Total Medical
346,976

 
338,563

 
681,043

 
659,129

Non-Medical
15,743

 
9,819

 
27,089

 
21,491

Total sales
$
362,719

 
$
348,382

 
$
708,132

 
$
680,620

Reconciliation of Operating Profit (Loss) from Segments to Consolidated
 
Three Months Ended
 
Six Months Ended
 
June 30,
2017
 
July 1,
2016
 
June 30,
2017
 
July 1,
2016
Segment income from operations:
 
 
 
 
 
 
 
Medical
$
55,233

 
$
41,869

 
$
105,593

 
$
73,710

Non-Medical
4,940

 
3,062

 
6,502

 
2,051

Total segment income from operations
60,173

 
44,931

 
112,095

 
75,761

Unallocated operating expenses
(20,434
)
 
(15,662
)
 
(45,811
)
 
(35,358
)
Operating income
39,739

 
29,269

 
66,284

 
40,403

Unallocated expenses, net
(35,623
)
 
(28,582
)
 
(66,363
)
 
(52,478
)
Income (loss) before provision for income taxes
$
4,116

 
$
687

 
$
(79
)
 
$
(12,075
)